$2.33
-0.05-2.10%
At close: -
$2.41
0.083.43%
After Hours: 9:12 AM EDT
Entera Bio reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Entera Bio using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-08 | $-0.08 | $-0.05 | -60.0 % |
Q2 | 2024-08-09 | $-0.06 | $-0.06 | 0.00 % |
Q1 | 2024-05-10 | $-0.05 | $-0.06 | 16.7 % |
Q3 | 2023-11-14 | $-0.08 | $-0.09 | 11.1 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-08 | $42.00K | $40.00K | 5.00 % |
Q1 | 2023-05-05 | $0 | $100.00K | -100.0 % |
Q4 | 2023-03-31 | $14.00K | $50.00K | -72.0 % |
Q3 | 2022-11-10 | $8.00K | $90.00K | -91.1 % |
Entera Bio (ENTX) is scheduled to report earnings on March 7, 2025. The last reported earnings were for reported on November 8, 2024 for Q3.
The Actual EPS was $-0.08, which missed the estimate of $-0.05.
The Actual Revenue was $42K, which beat the estimate of $40K.
Browse earnings estimates, EPS, and revenue on all stocks.